Cargando…

Early-Life Metabolic and Hormonal Markers in Blood and Growth until Age 2 Years: Results from a Randomized Controlled Trial in Healthy Infants Fed a Modified Low-Protein Infant Formula

Background: High protein intake in early life is associated with an increased risk of childhood obesity. Dietary protein intake may be a key mechanistic modulator through alterations in endocrine and metabolic responses. Objective: We aimed to determine the impact of different protein intake of infa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouwenhoven, Stefanie M. P., Fleddermann, Manja, Finken, Martijn J. J., Twisk, Jos W. R., van der Beek, Eline M., Abrahamse-Berkeveld, Marieke, van de Heijning, Bert J. M., van Harskamp, Dewi, van Goudoever, Johannes B., Koletzko, Berthold V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067012/
https://www.ncbi.nlm.nih.gov/pubmed/33915788
http://dx.doi.org/10.3390/nu13041159
_version_ 1783682702209187840
author Kouwenhoven, Stefanie M. P.
Fleddermann, Manja
Finken, Martijn J. J.
Twisk, Jos W. R.
van der Beek, Eline M.
Abrahamse-Berkeveld, Marieke
van de Heijning, Bert J. M.
van Harskamp, Dewi
van Goudoever, Johannes B.
Koletzko, Berthold V.
author_facet Kouwenhoven, Stefanie M. P.
Fleddermann, Manja
Finken, Martijn J. J.
Twisk, Jos W. R.
van der Beek, Eline M.
Abrahamse-Berkeveld, Marieke
van de Heijning, Bert J. M.
van Harskamp, Dewi
van Goudoever, Johannes B.
Koletzko, Berthold V.
author_sort Kouwenhoven, Stefanie M. P.
collection PubMed
description Background: High protein intake in early life is associated with an increased risk of childhood obesity. Dietary protein intake may be a key mechanistic modulator through alterations in endocrine and metabolic responses. Objective: We aimed to determine the impact of different protein intake of infants on blood metabolic and hormonal markers at the age of four months. We further aimed to investigate the association between these markers and anthropometric parameters and body composition until the age of two years. Design: Term infants received a modified low-protein formula (mLP) (1.7 g protein/100 kcal) or a specifically designed control formula (CTRL) (2.1 g protein/100 kcal) until 6 months of age in a double blinded RCT. The outcomes were compared with a breast-fed (BF) group. Glucose, insulin, leptin, IGF-1, IGF-BP1, -BP2, and -BP3 levels were measured at the age of 4 months. Anthropometric parameters and body composition were assessed until the age of 2 years. Groups were compared using linear regression analysis. Results: No significant differences were observed in any of the blood parameters between the formula groups (n = 53 mLP; n = 44 CTRL) despite a significant difference in protein intake. Insulin and HOMA-IR were higher in both formula groups compared to the BF group (n = 36) (p < 0.001). IGF-BP1 was lower in both formula groups compared to the BF group (p < 0.01). We found a lower IGF-BP2 level in the CTRL group compared to the BF group (p < 0.01) and a higher IGF-BP3 level in the mLP group compared to the BF group (p = 0.03). There were no significant differences in glucose, leptin, and IGF-1 between the three feeding groups. We found specific associations of all early-life metabolic and hormonal blood parameters with long-term growth and body composition except for IGF-1. Conclusions: Reducing protein intake by 20% did not result in a different metabolic profile in formula-fed infants at 4 months of age. Formula-fed infants had a lower insulin sensitivity compared to breast-fed infants. We found associations between all metabolic and hormonal markers (except for IGF-1) determined at age 4 months and growth and body composition up to two years of age.
format Online
Article
Text
id pubmed-8067012
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80670122021-04-25 Early-Life Metabolic and Hormonal Markers in Blood and Growth until Age 2 Years: Results from a Randomized Controlled Trial in Healthy Infants Fed a Modified Low-Protein Infant Formula Kouwenhoven, Stefanie M. P. Fleddermann, Manja Finken, Martijn J. J. Twisk, Jos W. R. van der Beek, Eline M. Abrahamse-Berkeveld, Marieke van de Heijning, Bert J. M. van Harskamp, Dewi van Goudoever, Johannes B. Koletzko, Berthold V. Nutrients Article Background: High protein intake in early life is associated with an increased risk of childhood obesity. Dietary protein intake may be a key mechanistic modulator through alterations in endocrine and metabolic responses. Objective: We aimed to determine the impact of different protein intake of infants on blood metabolic and hormonal markers at the age of four months. We further aimed to investigate the association between these markers and anthropometric parameters and body composition until the age of two years. Design: Term infants received a modified low-protein formula (mLP) (1.7 g protein/100 kcal) or a specifically designed control formula (CTRL) (2.1 g protein/100 kcal) until 6 months of age in a double blinded RCT. The outcomes were compared with a breast-fed (BF) group. Glucose, insulin, leptin, IGF-1, IGF-BP1, -BP2, and -BP3 levels were measured at the age of 4 months. Anthropometric parameters and body composition were assessed until the age of 2 years. Groups were compared using linear regression analysis. Results: No significant differences were observed in any of the blood parameters between the formula groups (n = 53 mLP; n = 44 CTRL) despite a significant difference in protein intake. Insulin and HOMA-IR were higher in both formula groups compared to the BF group (n = 36) (p < 0.001). IGF-BP1 was lower in both formula groups compared to the BF group (p < 0.01). We found a lower IGF-BP2 level in the CTRL group compared to the BF group (p < 0.01) and a higher IGF-BP3 level in the mLP group compared to the BF group (p = 0.03). There were no significant differences in glucose, leptin, and IGF-1 between the three feeding groups. We found specific associations of all early-life metabolic and hormonal blood parameters with long-term growth and body composition except for IGF-1. Conclusions: Reducing protein intake by 20% did not result in a different metabolic profile in formula-fed infants at 4 months of age. Formula-fed infants had a lower insulin sensitivity compared to breast-fed infants. We found associations between all metabolic and hormonal markers (except for IGF-1) determined at age 4 months and growth and body composition up to two years of age. MDPI 2021-04-01 /pmc/articles/PMC8067012/ /pubmed/33915788 http://dx.doi.org/10.3390/nu13041159 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kouwenhoven, Stefanie M. P.
Fleddermann, Manja
Finken, Martijn J. J.
Twisk, Jos W. R.
van der Beek, Eline M.
Abrahamse-Berkeveld, Marieke
van de Heijning, Bert J. M.
van Harskamp, Dewi
van Goudoever, Johannes B.
Koletzko, Berthold V.
Early-Life Metabolic and Hormonal Markers in Blood and Growth until Age 2 Years: Results from a Randomized Controlled Trial in Healthy Infants Fed a Modified Low-Protein Infant Formula
title Early-Life Metabolic and Hormonal Markers in Blood and Growth until Age 2 Years: Results from a Randomized Controlled Trial in Healthy Infants Fed a Modified Low-Protein Infant Formula
title_full Early-Life Metabolic and Hormonal Markers in Blood and Growth until Age 2 Years: Results from a Randomized Controlled Trial in Healthy Infants Fed a Modified Low-Protein Infant Formula
title_fullStr Early-Life Metabolic and Hormonal Markers in Blood and Growth until Age 2 Years: Results from a Randomized Controlled Trial in Healthy Infants Fed a Modified Low-Protein Infant Formula
title_full_unstemmed Early-Life Metabolic and Hormonal Markers in Blood and Growth until Age 2 Years: Results from a Randomized Controlled Trial in Healthy Infants Fed a Modified Low-Protein Infant Formula
title_short Early-Life Metabolic and Hormonal Markers in Blood and Growth until Age 2 Years: Results from a Randomized Controlled Trial in Healthy Infants Fed a Modified Low-Protein Infant Formula
title_sort early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067012/
https://www.ncbi.nlm.nih.gov/pubmed/33915788
http://dx.doi.org/10.3390/nu13041159
work_keys_str_mv AT kouwenhovenstefaniemp earlylifemetabolicandhormonalmarkersinbloodandgrowthuntilage2yearsresultsfromarandomizedcontrolledtrialinhealthyinfantsfedamodifiedlowproteininfantformula
AT fleddermannmanja earlylifemetabolicandhormonalmarkersinbloodandgrowthuntilage2yearsresultsfromarandomizedcontrolledtrialinhealthyinfantsfedamodifiedlowproteininfantformula
AT finkenmartijnjj earlylifemetabolicandhormonalmarkersinbloodandgrowthuntilage2yearsresultsfromarandomizedcontrolledtrialinhealthyinfantsfedamodifiedlowproteininfantformula
AT twiskjoswr earlylifemetabolicandhormonalmarkersinbloodandgrowthuntilage2yearsresultsfromarandomizedcontrolledtrialinhealthyinfantsfedamodifiedlowproteininfantformula
AT vanderbeekelinem earlylifemetabolicandhormonalmarkersinbloodandgrowthuntilage2yearsresultsfromarandomizedcontrolledtrialinhealthyinfantsfedamodifiedlowproteininfantformula
AT abrahamseberkeveldmarieke earlylifemetabolicandhormonalmarkersinbloodandgrowthuntilage2yearsresultsfromarandomizedcontrolledtrialinhealthyinfantsfedamodifiedlowproteininfantformula
AT vandeheijningbertjm earlylifemetabolicandhormonalmarkersinbloodandgrowthuntilage2yearsresultsfromarandomizedcontrolledtrialinhealthyinfantsfedamodifiedlowproteininfantformula
AT vanharskampdewi earlylifemetabolicandhormonalmarkersinbloodandgrowthuntilage2yearsresultsfromarandomizedcontrolledtrialinhealthyinfantsfedamodifiedlowproteininfantformula
AT vangoudoeverjohannesb earlylifemetabolicandhormonalmarkersinbloodandgrowthuntilage2yearsresultsfromarandomizedcontrolledtrialinhealthyinfantsfedamodifiedlowproteininfantformula
AT koletzkobertholdv earlylifemetabolicandhormonalmarkersinbloodandgrowthuntilage2yearsresultsfromarandomizedcontrolledtrialinhealthyinfantsfedamodifiedlowproteininfantformula